These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2984066)
1. Characterization of immunoreactive beta-endorphin secreted from cultured human corticotropin-secreting adenomas. Westphal M; Li CH; Wilson CB Mol Cell Endocrinol; 1985 Mar; 39(3):229-35. PubMed ID: 2984066 [TBL] [Abstract][Full Text] [Related]
2. In vitro secretion of pro-opiomelanocortin (POMC) derived peptides in human ACTH-producing pituitary adenomas: evaluation of hormone ratios in different functional states. Westphal M; Lüdecke DK Mol Cell Endocrinol; 1984 Sep; 37(2):145-51. PubMed ID: 6092171 [TBL] [Abstract][Full Text] [Related]
3. Chromatographic characteristics of pro-opiomelanocortin-derived peptides from the rat transplantable tumour 7315a. Morano MI; Estivariz FE J Endocrinol; 1987 Mar; 112(3):417-25. PubMed ID: 3031191 [TBL] [Abstract][Full Text] [Related]
4. Long-term culture of human corticotropin-secreting adenomas on extracellular matrix and evaluation of serum-free conditions. Secretory aspects. Westphal M; Jaquet P; Wilson CB Acta Neuropathol; 1986; 71(1-2):111-8. PubMed ID: 3022531 [TBL] [Abstract][Full Text] [Related]
5. Characterization of peptides derived from pro-opiomelanocortin in the biological fluids of a patient with Nelson's syndrome. Gaspar L; Chan JS; Seidah NG; Chrétien M Clin Invest Med; 1985; 8(2):167-75. PubMed ID: 3009068 [TBL] [Abstract][Full Text] [Related]
6. Characterization of lipotropin-, corticotropin-, and beta-endorphin-immunoreactive materials secreted in vitro by a human pituitary adenoma responsible for a case of Nelson's syndrome. Bertagna X; Luton JP; Binoux M; Bricaire H; Girard F J Clin Endocrinol Metab; 1979 Oct; 49(4):527-32. PubMed ID: 225344 [TBL] [Abstract][Full Text] [Related]
7. Multiple forms of immunoreactive beta-endorphin are present in an ectopic adrenocorticotropin-producing tumor but not in normal pituitary or pituitary adenomas. Suda T; Tozawa F; Yamaguchi H; Shibasaki T; Demura H; Shizume K J Clin Endocrinol Metab; 1982 Jan; 54(1):167-71. PubMed ID: 6274895 [TBL] [Abstract][Full Text] [Related]
8. Diurnal rhythms of proopiomelanocortin-derived N-terminal peptide, beta-lipotropin, beta-endorphin and adrenocorticotropin in normal subjects and in patients with Addison's disease and Cushing's disease. Sekiya K; Nawata H; Kato K; Motomatsu T; Ibayashi H Endocrinol Jpn; 1986 Oct; 33(5):713-9. PubMed ID: 3030713 [TBL] [Abstract][Full Text] [Related]
9. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro. Chan JS; Lu CL; Seidah NG; Chretien M Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359 [TBL] [Abstract][Full Text] [Related]
10. Effects of ovine corticotropin-releasing hormone and FK 33-824 (met-enkephalin analogue) on the secretions of proopiomelanocortin-derived N-terminal peptide, beta-lipotropin, beta-endorphin and adrenocorticotropin in patients with Addison's disease. Sekiya K; Nawata H; Kato K; Motomatsu T; Ibayashi H Endocrinol Jpn; 1986 Dec; 33(6):761-8. PubMed ID: 3034555 [TBL] [Abstract][Full Text] [Related]
11. A pituitary tumor producing high molecular weight adrenocorticotropin-related peptides: clinical and cell culture studies. Fuller PJ; Lim AT; Barlow JW; White EL; Khalid BA; Copolov DL; Lolait S; Funder JW; Stockigt JR J Clin Endocrinol Metab; 1984 Jan; 58(1):134-42. PubMed ID: 6315755 [TBL] [Abstract][Full Text] [Related]
12. ACTH, beta-LPH and beta-endorphin in pituitary adenomas of the patients with Cushing's disease: activation of beta-LPH conversion to beta-endorphin. Suda T; Abe Y; Demura H; Demura R; Shizume K; Tamahashi N; Sasano N J Clin Endocrinol Metab; 1979 Sep; 49(3):475-7. PubMed ID: 224076 [TBL] [Abstract][Full Text] [Related]
13. ACTH and beta-endorphin secretion by three corticotrophic adenomas in culture. Effects of culture time, dexamethasone, vasopressin and synthetic corticotrophin releasing factor. Oosterom R; Verleun T; Uitterlinden P; Hackeng WH; Burbach JP; Wiegant VM; Lamberts SW Acta Endocrinol (Copenh); 1984 May; 106(1):21-9. PubMed ID: 6328819 [TBL] [Abstract][Full Text] [Related]
14. Adrenocorticotropin, beta-endorphin, and beta-lipotropin in normal thyroid and lung: possible implications for ectopic hormone secretion. Clements JA; Funder JW; Tracy K; Morgan FJ; Campbell DJ; Lewis P; Hearn MT Endocrinology; 1982 Dec; 111(6):2097-102. PubMed ID: 6291910 [TBL] [Abstract][Full Text] [Related]
15. [Lipocorticotropic peptides in Cushing's disease: in vitro studies]. Boudouresque F; Lissitzky JC; Jaquet P; Guibout M; Goldstein E; Grisoli F; Oliver C Horm Res; 1980; 13(4-5):242-58. PubMed ID: 6268512 [TBL] [Abstract][Full Text] [Related]
16. In vitro secretion of ACTH, beta-endorphin and beta-lipotropin in Cushing's disease and Nelson's syndrome. Lüdecke DK; Westphal M; Schabet M; Höllt V Horm Res; 1980; 13(4-5):259-79. PubMed ID: 6268513 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of human plasma immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin using immuno-affinity chromatography. Yamaguchi H; Liotta AS; Krieger DT J Clin Endocrinol Metab; 1980 Nov; 51(5):1002-8. PubMed ID: 6252227 [TBL] [Abstract][Full Text] [Related]